Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Zimmer Biomet's Knee Therapy Hit With Expanded FDA Safety Claim - Orthopedic Design & Technology
OEM News

Zimmer Biomet’s Knee Therapy Hit With Expanded FDA Safety Claim

Single-injection viscosupplement is safe for repeat treatments.

Zimmer Biomet Holdings Inc.’s Gel-One Cross-linked Hyaluronate, an advanced joint preservation treatment for knee osteoarthritis has received expanded safety claim from the U.S. Food and Drug Administration (FDA). As per this expanded FDA safety claim, this single-injection viscosupplement is safe for repeat treatments.

According to Zimmer Biomet, Gel-One Hyaluronate is the first low-volume viscosupplement available in a single-injection formulation for knee osteoarthritis patients, who have failed to respond adequately to non-pharmacologic therapy, non-steroidal anti-inflammatory drugs (NSAIDs) or simple analgesics, such as acetaminophen.

Hyaluronic acid (HA) products such as Gel-One Hyaluronate work as a supplement for the natural lubrication of the joint. With the expanded safety claim, physicians will now be able to safely utilize Zimmer Biomet’s knee joint solution in repeat treatment courses if required, to provide continued pain relief for patients. The decision comes as an encouraging development for Zimmer Biomet’ as it will help substantially expand the company’s portfolio of joint preservation treatments.

The combined company is working to advance innovation and help create a more diversified and predictable revenue mix consistent with a comprehensive portfolio. Zimmer Biomet currently plans to invest more in research and development, and medical training and education, with an aim to develop and introduce cutting-edge musculoskeletal products and services to achieve improved patient outcomes.

 

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters